vs

Side-by-side financial comparison of PAR TECHNOLOGY CORP (PAR) and Vericel Corp (VCEL). Click either name above to swap in a different company.

PAR TECHNOLOGY CORP is the larger business by last-quarter revenue ($120.1M vs $92.9M, roughly 1.3× Vericel Corp). On growth, Vericel Corp posted the faster year-over-year revenue change (23.3% vs 14.4%). Vericel Corp produced more free cash flow last quarter ($12.8M vs $-12.5M). Over the past eight quarters, Vericel Corp's revenue compounded faster (34.6% CAGR vs 30.9%).

PAR Technology Corp is a global provider of point-of-sale systems, restaurant management software, and integrated tech solutions. Its core segments serve food service, hospitality, and government security markets, offering cloud tools to streamline operations, enhance customer experiences, and boost efficiency for enterprise and small-to-medium clients.

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan.

PAR vs VCEL — Head-to-Head

Bigger by revenue
PAR
PAR
1.3× larger
PAR
$120.1M
$92.9M
VCEL
Growing faster (revenue YoY)
VCEL
VCEL
+8.9% gap
VCEL
23.3%
14.4%
PAR
More free cash flow
VCEL
VCEL
$25.4M more FCF
VCEL
$12.8M
$-12.5M
PAR
Faster 2-yr revenue CAGR
VCEL
VCEL
Annualised
VCEL
34.6%
30.9%
PAR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PAR
PAR
VCEL
VCEL
Revenue
$120.1M
$92.9M
Net Profit
$23.2M
Gross Margin
41.2%
78.7%
Operating Margin
-15.0%
24.1%
Net Margin
25.0%
Revenue YoY
14.4%
23.3%
Net Profit YoY
17.3%
EPS (diluted)
$-0.52
$0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PAR
PAR
VCEL
VCEL
Q4 25
$120.1M
$92.9M
Q3 25
$119.2M
$67.5M
Q2 25
$112.4M
$63.2M
Q1 25
$103.9M
$52.6M
Q4 24
$105.0M
$75.4M
Q3 24
$96.8M
$57.9M
Q2 24
$78.2M
$52.7M
Q1 24
$70.1M
$51.3M
Net Profit
PAR
PAR
VCEL
VCEL
Q4 25
$23.2M
Q3 25
$-18.2M
$5.1M
Q2 25
$-21.0M
$-553.0K
Q1 25
$-24.4M
$-11.2M
Q4 24
$19.8M
Q3 24
$-19.8M
$-901.0K
Q2 24
$54.2M
$-4.7M
Q1 24
$-18.3M
$-3.9M
Gross Margin
PAR
PAR
VCEL
VCEL
Q4 25
41.2%
78.7%
Q3 25
41.3%
73.5%
Q2 25
45.4%
73.7%
Q1 25
46.5%
69.0%
Q4 24
42.9%
77.6%
Q3 24
44.5%
71.9%
Q2 24
41.0%
69.5%
Q1 24
37.2%
68.9%
Operating Margin
PAR
PAR
VCEL
VCEL
Q4 25
-15.0%
24.1%
Q3 25
-14.8%
5.1%
Q2 25
-15.4%
-3.2%
Q1 25
-15.2%
-24.3%
Q4 24
-15.6%
24.5%
Q3 24
-15.7%
-4.3%
Q2 24
-26.5%
-11.5%
Q1 24
-38.2%
-10.7%
Net Margin
PAR
PAR
VCEL
VCEL
Q4 25
25.0%
Q3 25
-15.3%
7.5%
Q2 25
-18.7%
-0.9%
Q1 25
-23.4%
-21.4%
Q4 24
26.3%
Q3 24
-20.5%
-1.6%
Q2 24
69.3%
-8.9%
Q1 24
-26.1%
-7.5%
EPS (diluted)
PAR
PAR
VCEL
VCEL
Q4 25
$-0.52
$0.46
Q3 25
$-0.45
$0.10
Q2 25
$-0.52
$-0.01
Q1 25
$-0.60
$-0.23
Q4 24
$-0.56
$0.40
Q3 24
$-0.56
$-0.02
Q2 24
$1.60
$-0.10
Q1 24
$-0.62
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PAR
PAR
VCEL
VCEL
Cash + ST InvestmentsLiquidity on hand
$80.1M
$137.5M
Total DebtLower is stronger
$394.0M
Stockholders' EquityBook value
$825.1M
$354.6M
Total Assets
$1.4B
$488.0M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PAR
PAR
VCEL
VCEL
Q4 25
$80.1M
$137.5M
Q3 25
$93.0M
$135.4M
Q2 25
$85.7M
$116.9M
Q1 25
$92.2M
$112.9M
Q4 24
$108.6M
$116.2M
Q3 24
$118.4M
$101.7M
Q2 24
$142.5M
$102.5M
Q1 24
$72.5M
$110.6M
Total Debt
PAR
PAR
VCEL
VCEL
Q4 25
$394.0M
Q3 25
$393.4M
Q2 25
$392.8M
Q1 25
$392.3M
Q4 24
$368.4M
Q3 24
$466.7M
Q2 24
$378.7M
Q1 24
$378.2M
Stockholders' Equity
PAR
PAR
VCEL
VCEL
Q4 25
$825.1M
$354.6M
Q3 25
$838.0M
$321.9M
Q2 25
$859.1M
$306.8M
Q1 25
$852.0M
$295.5M
Q4 24
$871.7M
$292.0M
Q3 24
$692.7M
$257.5M
Q2 24
$588.3M
$243.0M
Q1 24
$526.4M
$233.9M
Total Assets
PAR
PAR
VCEL
VCEL
Q4 25
$1.4B
$488.0M
Q3 25
$1.4B
$453.3M
Q2 25
$1.4B
$435.6M
Q1 25
$1.4B
$424.6M
Q4 24
$1.4B
$432.7M
Q3 24
$1.3B
$390.4M
Q2 24
$1.1B
$376.8M
Q1 24
$1.0B
$356.7M
Debt / Equity
PAR
PAR
VCEL
VCEL
Q4 25
0.48×
Q3 25
0.47×
Q2 25
0.46×
Q1 25
0.46×
Q4 24
0.42×
Q3 24
0.67×
Q2 24
0.64×
Q1 24
0.72×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PAR
PAR
VCEL
VCEL
Operating Cash FlowLast quarter
$-11.8M
$15.0M
Free Cash FlowOCF − Capex
$-12.5M
$12.8M
FCF MarginFCF / Revenue
-10.4%
13.8%
Capex IntensityCapex / Revenue
0.7%
2.4%
Cash ConversionOCF / Net Profit
0.65×
TTM Free Cash FlowTrailing 4 quarters
$-30.5M
$24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PAR
PAR
VCEL
VCEL
Q4 25
$-11.8M
$15.0M
Q3 25
$8.4M
$22.1M
Q2 25
$-6.6M
$8.2M
Q1 25
$-17.2M
$6.6M
Q4 24
$3.4M
$22.2M
Q3 24
$8.8M
$10.2M
Q2 24
$-13.8M
$18.5M
Q1 24
$-23.6M
$7.2M
Free Cash Flow
PAR
PAR
VCEL
VCEL
Q4 25
$-12.5M
$12.8M
Q3 25
$7.0M
$19.5M
Q2 25
$-7.4M
$81.0K
Q1 25
$-17.6M
$-7.6M
Q4 24
$3.2M
$8.5M
Q3 24
$8.4M
$-9.2M
Q2 24
$-14.2M
$1.8M
Q1 24
$-23.6M
$-6.8M
FCF Margin
PAR
PAR
VCEL
VCEL
Q4 25
-10.4%
13.8%
Q3 25
5.9%
28.8%
Q2 25
-6.6%
0.1%
Q1 25
-16.9%
-14.5%
Q4 24
3.0%
11.2%
Q3 24
8.7%
-15.9%
Q2 24
-18.2%
3.4%
Q1 24
-33.7%
-13.3%
Capex Intensity
PAR
PAR
VCEL
VCEL
Q4 25
0.7%
2.4%
Q3 25
1.1%
3.9%
Q2 25
0.7%
12.9%
Q1 25
0.4%
27.0%
Q4 24
0.2%
18.3%
Q3 24
0.4%
33.5%
Q2 24
0.5%
31.8%
Q1 24
0.1%
27.3%
Cash Conversion
PAR
PAR
VCEL
VCEL
Q4 25
0.65×
Q3 25
4.35×
Q2 25
Q1 25
Q4 24
1.12×
Q3 24
Q2 24
-0.26×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PAR
PAR

Subscription Service$76.1M63%
Hardware$27.8M23%
Professional Service$16.2M13%

VCEL
VCEL

MACI Implants And Kits$84.1M90%
Other$8.8M10%

Related Comparisons